Core Insights - Publicis Groupe celebrates its centenary in 2026, marking a significant transformation from a small creative shop in Montmartre to the industry's leading holding company [1][3] - The company emphasizes resilience and innovation, having overcome various challenges throughout its history, including wars, economic downturns, and a global pandemic [2][4] - The rise of AI is expected to define the next century for Publicis, with a focus on blending human creativity with advanced AI capabilities [5] Company Overview - Publicis Groupe was founded in 1926 and has evolved into a global leader in communication, employing around 103,000 professionals across over 100 countries [11] - The company operates across four main activities: Communication, Media, Data, and Technology, providing a unified approach to client transformation [11] Film Project - The film "A Lion Never Gives Up" is a hybrid project that combines live action and AI-generated content, showcasing the company's history and resilience [5][6] - A quarter of the film consists of live action footage, while the remainder is created using AI, utilizing 4,500 real images for 150 individual shots [6][7] - The editing process for the film is reinvented, allowing for flexibility and regeneration of each shot from scratch [8]

Core Insights - Enlivex Therapeutics Ltd. will host a virtual fireside chat on December 11, 2025, to discuss its recent $212 million private placement and future plans [1][2][3] - The company is focusing on advancing the clinical development of Allocetra™, a therapy for osteoarthritis, which affects over 32.5 million Americans and 300 million people globally [5] Company Plans - Shai Novik, Executive Chairman, will provide updates on the digital asset treasury strategy centered around RAIN token accumulation [2] - Enlivex aims to offer investors exposure to RAIN as a primary treasury reserve asset [4] Clinical Development - Allocetra™ is designed to treat osteoarthritis, a prevalent joint disease with significant hospitalization rates in the U.S. [5] - There are currently no FDA or EMA approved medications that can halt or reverse joint damage in osteoarthritis patients [5]

Drilling Confirms Historical Grades and Extends Mineralization Along North–Northwest TrendCALGARY, Alberta, Dec. 04, 2025 (GLOBE NEWSWIRE) -- Integral Metals Corp. (CSE: INTG | FSE: ZK9) (the “Company” or “Integral”) is pleased to announce assay results from the seven diamond drill holes completed during the 2025 program at the KAP Project in the Mackenzie Mountains, Northwest Territories, Canada. Drilling successfully confirmed the presence of zinc (Zn) mineralization with associated gallium (Ga) and germa ...

- Bitcoin treasury as of November 30, 2025 valued at $27.5 million or $2.25 per share1 TAMPA, Fla., Dec. 04, 2025 (GLOBE NEWSWIRE) -- LM Funding America, Inc. (NASDAQ: LMFA) (“LM Funding” or the “Company”), a Bitcoin treasury and mining company, today announced its preliminary, unaudited Bitcoin mining and operational update for the month ended November 30, 2025. MetricOctober 2025November 2025 - Bitcoin2 - Mined, net7.56.9<td style="border-top: solid black 1pt ; border-right: solid black 1pt ; border-bot ...

CALGARY, Alberta, Dec. 04, 2025 (GLOBE NEWSWIRE) -- Traction Uranium Corp. (CSE: TRAC) (OTC: TRCTF) (FRA: Z1K) (the “Company” or “Traction”) is pleased to announce the appointment of Dr. Jared Suchan as Director and Chief Executive Officer of the Company. Dr. Suchan is a professional geoscientist with more than a decade of experience advancing mineral exploration projects across Canada and the United States, working in diverse geological settings that include uranium, rare earth elements, lithium, diamonds, ...

Core Insights - American Rebel Holdings, Inc. has announced a strategic distribution partnership with Mid-State Beverage Company, enhancing its presence in central and northern Pennsylvania for American Rebel Light Beer [1][2][8] - This partnership is part of a broader distribution strategy that has seen American Rebel secure multiple top-tier distributors in a short timeframe, indicating strong momentum in its growth strategy [2][11] Distribution Strategy - The agreement with Mid-State marks American Rebel's third major distributor in Pennsylvania and its fourth new wholesaler in less than three weeks [2][10] - The distribution momentum was initiated at the 2025 National Beer Wholesalers Association (NBWA) Annual Convention, where American Rebel engaged with over 110 distributors, resulting in 83 qualified follow-ups [2][11] - The company is in late-stage discussions with additional wholesalers to further expand its reach in Pennsylvania [2] Mid-State Beverage Company Profile - Mid-State Beverage Company, established in 1970, is recognized as a leading beverage wholesaler in north-central Pennsylvania, servicing thousands of accounts across 12 counties [3][4] - The company is known for its strong relationships with retailers and has a proven track record of performance, having received Diageo's Golden Bar Award [7][9] Product Overview - American Rebel Light Beer is a premium domestic light lager with approximately 100 calories, 3.2g of carbohydrates, and 4.3% ABV per 12 oz serving, crafted without corn, rice, or added sweeteners [12][13] - The beer is positioned as "America's Patriotic, God-Fearing, Constitution-Loving, National Anthem-Singing, Stand-Your-Ground Beer," appealing to consumers seeking a patriotic brand [12][14] Market Expansion - The partnership with Mid-State allows American Rebel to leverage a robust distribution network, enhancing its ability to compete alongside established brands like Coors Light and Miller Lite from day one [7][8] - The company has secured distribution in 17 states and continues to expand its footprint through partnerships with strong family-owned wholesalers [13][16]

DELAWARE, Ohio, Dec. 04, 2025 (GLOBE NEWSWIRE) -- Greif, Inc. (NYSE: GEF, GEF.B), a global leader in performance packaging products and services, today announced that it has been named to Newsweek’s America’s Most Responsible Companies 2026 list - for a seventh consecutive year. Greif has been included on the list every year since its inception, underscoring the company’s long-standing commitment to environmental stewardship, social responsibility, and strong corporate governance. This consistency reflects ...

Study to evaluate safety and efficacy of novel anti-PRLR antibody; interim data anticipated in the second half of 2026 Trial design leverages operational synergies to enable accelerated registrational trials for androgenetic alopecia (AGA) and Phase 2 for endometriosis KOL seminar scheduled for December 11 to discuss new human ex vivo data, clinical trial design, and market opportunity in AGA VANCOUVER, Wash. and NEW YORK, Dec. 04, 2025 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), a clinical-stage ...

Core Insights - Aclarion, Inc. has announced the publication of a featured article in the Special Pain Issue of the International Journal of Spine Surgery, highlighting the importance of understanding pain as a complex condition and showcasing their Nociscan solution for chronic low back pain [1][2][4] Company Overview - Aclarion is a healthcare technology company focused on leveraging biomarkers and proprietary AI algorithms to assist physicians in identifying chronic low back pain locations [1][6] - The company’s Nociscan solution is the first evidence-supported SaaS platform designed to noninvasively differentiate between painful and nonpainful discs in the lumbar spine [2][7] Product Details - Nociscan utilizes Magnetic Resonance Spectroscopy (MRS) data to extract and quantify chemical biomarkers associated with disc pain, providing critical insights for treatment optimization [6][7] - A case study featured in the publication demonstrated Nociscan's effectiveness in identifying the source of pain, leading to successful surgical intervention for a patient [3][4] Industry Context - The Special Pain Issue of IJSS emphasizes the evolving understanding of pain, integrating objective biomarkers with clinical judgment to enhance diagnosis and treatment [2][4] - IJSS is recognized for advancing scientific and clinical excellence in spine care, publishing over 150 articles annually from over 40 nations [4][6]

Neuphoria Will Continue its Well-Planned Strategic Alternatives Review, Which has Garnered Significant Positive Interest Urges Stockholders to Vote “FOR” BOTH of Neuphoria’s Nominees on the WHITE Proxy Card BURLINGTON, Mass., Dec. 04, 2025 (GLOBE NEWSWIRE) -- Neuphoria Therapeutics Inc. (“Neuphoria” or the “Company”) (NASDAQ: NEUP), a clinical-stage biotechnology company dedicated to developing therapies that address the complex needs of individuals affected by neuropsychiatric disorders, today issued the f ...